KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) Gross Margin: 2013-2025

Historic Gross Margin for Xenon Pharmaceuticals (XENE) over the last 9 years, with Mar 2025 value amounting to 100.00%.

  • Xenon Pharmaceuticals' Gross Margin was N/A to 100.00% in Q1 2025 from the same period last year, while for Mar 2025 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2022, which is negligibly% changed negligibly from last year.
  • Xenon Pharmaceuticals' Gross Margin amounted to 100.00% in Q1 2025, which was down 0.00% from 100.00% recorded in Q3 2022.
  • Over the past 5 years, Xenon Pharmaceuticals' Gross Margin peaked at 100.00% during Q1 2021, and registered a low of 100.00% during Q1 2021.
  • Its 1-year average for Gross Margin is 100.00%, with a median of 100.00% in 2025.